Logo image of VPT.CA

VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:VPT - CA92281P2008 - Common Stock

0.1 CAD
+0.01 (+5.26%)
Last: 12/10/2025, 7:00:00 PM
Fundamental Rating

1

Overall VPT gets a fundamental rating of 1 out of 10. We evaluated VPT against 16 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of VPT have multiple concerns. VPT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

VPT had negative earnings in the past year.
In the past year VPT has reported a negative cash flow from operations.
VPT had negative earnings in each of the past 5 years.
VPT had a negative operating cash flow in each of the past 5 years.
VPT.CA Yearly Net Income VS EBIT VS OCF VS FCFVPT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

VPT's Return On Assets of -1076.66% is on the low side compared to the rest of the industry. VPT is outperformed by 81.25% of its industry peers.
Industry RankSector Rank
ROA -1076.66%
ROE N/A
ROIC N/A
ROA(3y)-362.62%
ROA(5y)-271.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VPT.CA Yearly ROA, ROE, ROICVPT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K

1.3 Margins

VPT has a Gross Margin (54.21%) which is in line with its industry peers.
In the last couple of years the Gross Margin of VPT has grown nicely.
The Profit Margin and Operating Margin are not available for VPT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y16.84%
VPT.CA Yearly Profit, Operating, Gross MarginsVPT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

0

2. Health

2.1 Basic Checks

VPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VPT has more shares outstanding
The number of shares outstanding for VPT has been increased compared to 5 years ago.
VPT has a worse debt/assets ratio than last year.
VPT.CA Yearly Shares OutstandingVPT.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
VPT.CA Yearly Total Debt VS Total AssetsVPT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

Based on the Altman-Z score of -272.93, we must say that VPT is in the distress zone and has some risk of bankruptcy.
VPT's Altman-Z score of -272.93 is on the low side compared to the rest of the industry. VPT is outperformed by 81.25% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -272.93
ROIC/WACCN/A
WACC7.38%
VPT.CA Yearly LT Debt VS Equity VS FCFVPT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

2.3 Liquidity

A Current Ratio of 0.05 indicates that VPT may have some problems paying its short term obligations.
The Current ratio of VPT (0.05) is worse than 87.50% of its industry peers.
A Quick Ratio of 0.05 indicates that VPT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.05, VPT is doing worse than 87.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
VPT.CA Yearly Current Assets VS Current LiabilitesVPT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.15% over the past year.
VPT shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.55%.
Measured over the past years, VPT shows a small growth in Revenue. The Revenue has been growing by 3.28% on average per year.
EPS 1Y (TTM)23.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.04%
Revenue 1Y (TTM)28.55%
Revenue growth 3YN/A
Revenue growth 5Y3.28%
Sales Q2Q%61.71%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VPT.CA Yearly Revenue VS EstimatesVPT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 50K 100K 150K 200K 250K

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VPT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VPT.CA Price Earnings VS Forward Price EarningsVPT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VPT.CA Per share dataVPT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0 -0.01 -0.01 -0.02 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for VPT!.
Industry RankSector Rank
Dividend Yield N/A

VENTRIPOINT DIAGNOSTICS LTD

TSX-V:VPT (12/10/2025, 7:00:00 PM)

0.1

+0.01 (+5.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-28 2025-11-28
Earnings (Next)04-28 2026-04-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners2.08%
Ins Owner ChangeN/A
Market Cap16.77M
Revenue(TTM)175.60K
Net Income(TTM)-4.06M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 95.5
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS-0.03
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1076.66%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.21%
FCFM N/A
ROA(3y)-362.62%
ROA(5y)-271.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y16.84%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z -272.93
F-Score4
WACC7.38%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)28.55%
Revenue growth 3YN/A
Revenue growth 5Y3.28%
Sales Q2Q%61.71%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.54%
OCF growth 3YN/A
OCF growth 5YN/A

VENTRIPOINT DIAGNOSTICS LTD / VPT.CA FAQ

What is the ChartMill fundamental rating of VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to VPT.CA.


Can you provide the valuation status for VENTRIPOINT DIAGNOSTICS LTD?

ChartMill assigns a valuation rating of 0 / 10 to VENTRIPOINT DIAGNOSTICS LTD (VPT.CA). This can be considered as Overvalued.


What is the profitability of VPT stock?

VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) has a profitability rating of 1 / 10.